Premier Biomedical (Premier Biomedical) Debt-to-Equity : -0.09 (As of Dec. 2019)

View and export this data going back to 2012. Start your Free Trial

What is Premier Biomedical Debt-to-Equity?

Premier Biomedical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2019 was $0.16 Mil. Premier Biomedical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2019 was $0.00 Mil. Premier Biomedical's Total Stockholders Equity for the quarter that ended in Dec. 2019 was $-1.83 Mil. Premier Biomedical's debt to equity for the quarter that ended in Dec. 2019 was -0.09.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Premier Biomedical's Debt-to-Equity or its related term are showing as below:

BIEI's Debt-to-Equity is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.29
* Ranked among companies with meaningful Debt-to-Equity only.

Premier Biomedical Debt-to-Equity Historical Data

The historical data trend for Premier Biomedical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Premier Biomedical Debt-to-Equity Chart

Premier Biomedical Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Debt-to-Equity

Get a 7-Day Free Trial

-0.17

-0.28

-0.07

-0.14

-0.09

Premier Biomedical Quarterly Data
	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19
Debt-to-Equity	Get a 7-Day Free Trial															-0.14	-0.13	-0.12	-0.09	-0.09

Competitive Comparison of Premier Biomedical's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Premier Biomedical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Premier Biomedical's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Premier Biomedical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Premier Biomedical's Debt-to-Equity falls into.

Premier Biomedical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Premier Biomedical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2019 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.161	+	0)	/	-1.833
	=	-0.09

Premier Biomedical's Debt to Equity Ratio for the quarter that ended in Dec. 2019 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.161	+	0)	/	-1.833
	=	-0.09

Premier Biomedical (OTCPK:BIEI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Premier Biomedical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Premier Biomedical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Premier Biomedical (Premier Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Premier Biomedical Inc (OTCPK:BIEI) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

2409 Sycamore Drive, Knoxville, TN, USA, 37921

Website

https://www.premiergrapheneinc.com

Premier Biomedical Inc is engaged in a hemp-based initiative, developing graphene-enhanced formulations for a myriad of commercial and military applications.